Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Vigabatrin
Also marketed in the EU under the name(s): Sabril, Sabrilex
Active substance: vigabatrin
Indication: Treatment of epilepsy
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/1999 Referral (1999)3195 of 05/10/1999